阿尔茨海默病的多组织甲基化分析:对途径,模块和关键基因的洞察
Tianshu Zhu1, Yue Wang2, Han Wang3
1Department of Clinical Laboratory, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China.
Journal of molecular neuroscience : MN
|July 16, 2025
概括
DNA甲基化是阿尔茨海默病 (AD) 进展的关键. 一个新的多甲基化评分 (PMS) 将甲基化模式与认知衰退联系起来,识别了THBS1和TGFB1等关键基因,用于潜在的AD干预.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
背景情况:
- DNA甲基化与阿尔茨海默病 (AD) 病原发生有关.
- 跨多个组织的全基因组甲基化分析为AD病理学和潜在生物标志物提供了洞察力.
研究的目的:
- 确定与AD相关的途径,并制定多甲基化评分 (PMS).
- 使用计算和实验方法,精确确定参与AD病变的关键基因.
- 为了研究PMS和AD表型之间的纵向关联.
主要方法:
- 多组织数据的全基因组甲基化分析.
- 路径分析和蛋白质-蛋白质相互作用网络的构建.
- 在β-粉样蛋白42诱导的细胞模型和线性混合效应建模中的验证.
主要成果:
- 与AD相关的甲基化途径显示了组织特异性,关键基因被确定为THBS1 (血液),TGFB1 (额叶皮层),HIF1A (神经元) 和KLF4 (质细胞).
- 在SH-SY5Y,HMC3和THP-1细胞模型中验证了基因表达的改变.
- 较高的PMS与大脑代谢率和认知功能的加速下降有显著的相关性.
结论:
- 对甲基化数据的机器学习分析增强了对AD病原学的理解.
- 已识别的关键基因 (THBS1,TGFB1,HIF1A,KLF4) 需要进一步研究,作为阿尔茨海默病的潜在治疗点.
相关概念视频
01:26Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
01:22Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263